Enteric-coated peppermint-oil capsules in the treatment of irritable bowel syndrome: A prospective, randomized trial

Abstract

To determine the efficacy and tolerability of an enteric-coated peppermint-oil formulation (Colpermin), we conducted a prospective, randomized, double-blind, placebo-controlled clinical study in 110 outpatients (66 men/44 women; 18-70 years of age) with symptoms of irritable bowel syndrome. Patients took one capsule (Colpermin or placebo) three to four times daily, 15-30 min before meals, for 1 month. Fifty-two patients on Colpermin and 49 on placebo completed the study. Forty-one patients on Colpermin (79%) experienced an alleviation of the severity of abdominal pain (29 were pain-free); 43 (83%) had less abdominal distension, 43 (83%) had reduced stool frequency, 38 (73%) had fewer borborygmi, and 41 (79%) less flatulence. Corresponding figures for the placebo group were: 21 patients (43%) with reduced pain (4 were pain-free), 14 (29%) with reduced distension, 16 (32%) with reduced stool frequency, 15 (31%) with fewer borborygmi, and 11 (22%) with less flatulence. Symptom improvements after Colpermin were significantly better than after placebo (P < 0.05; Mann-Whitney U-test). One patient on Colpermin experienced heartburn (because of chewing the capsules) and one developed a mild transient skin rash. There were no significant changes in liver function test results. Thus, in this trial, Colpermin was effective and well tolerated.

Comparing the Effects of Cumin, Peppermint, and Milk of Magnesia on Gastrointestinal Complications after Caesarean Section

“…The authors finally asserted the need for more accurate knowledge about the efficacy and safety of herbal medicines in pregnancy (Holst, Wright, Haavik, & Nordeng, 2009). In addition, while patients generally take herbal supplements in combination with conventional drugs (Liu et al, 1997;Abebe, 2002), some researchers discuss that herbal medicines should be cautiously administered to prevent any possible adverse drug-herb interactions or complications such as bleeding (Hepner, 2002).…”

Clinical Practice Guideline: Irritable bowel syndrome with constipation and functional constipation in the adult

“…The most recent review included 5 trials for a total of 482 patients (107)(108)(109)(110)(111); it showed a statistically significant positive effect of peppermint oil versus placebo, with a NNT of 3 (95% CI: 2-4) (90). However, there was significant heterogeneity among studies.…”

Spicy In Means Spicy Out: Capsaicin-Associated Anal Burn (CAAB) in Three US Metropolitan Populations, a New Proposed Classification System

“…1,2 One of the significant pathophysiology of IBS is visceral hypersensitivity, which has been known to have both mechanical and chemical causes. Because postprandial gastrointestinal symptoms have been reported to develop in a significant number of patients following consumption of spicy food, Gonlachanvit et al, 2 conducted a randomized, crossover study feeding subjects with and without IBS subjects and found that IBS patients were significantly more likely to exhibit hypersensitivity when chili, both in pill form and in food form, was consumed.…”